Thursday, February 05, 2015
I clearly remember my first job in the industry following graduate school. One of the things that impressed me about my employer (Abbott Laboratories, a large multinational pharmaceutical company) was the broad spectrum of training that they offered ...
1. What, in your opinion, is currently the single largest trend with respect to strategic partnering?
SW: In my current work with a Chinese biopharmaceutical firm we see many companies that are seeking entry to the Chinese market place. These ...
For biopharmaceutical manufacturing, the greatest current
change is the impact of increasing expression levels on the
volume of capacity that is required for production.
MA:
The large companies with excess capacity are shedding that
capacity and looking for right-sized manufacturing. Drug
pipelines are inconsistent and it’s expensive to maintain idle capacity
for a pipeline that may or may not mature in the near ...
The manufacture of a biopharmaceutical is a complex process with many steps and materials used throughout the operation. While we often view certain key materials, such as cell culture media, chromatography resin or filling vials, as critical ...
Wednesday, September 01, 2010
As the world economy and financial markets contracted in 2009, so
did the market for biopharmaceutical contract manufacturer services.